{"id":2998,"date":"2017-09-12T12:40:00","date_gmt":"2017-09-12T12:40:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/"},"modified":"2017-09-12T12:40:00","modified_gmt":"2017-09-12T12:40:00","slug":"first-clinical-heart-transplant-performed-using-stig-steens-new-method","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/","title":{"rendered":"First clinical heart transplant performed using Stig Steen\u2019s new method"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Through its collaboration agreement with Igel\u00f6sa, XVIVO Perfusion has the commercial rights to Professor Stig Steen\u2019s research on heart transplants. The research has resulted in a method in connection with heart transplants that makes it possible to transport and preserve the heart from a donor in a more optimized way. Previous animal experiments have demonstrated that the method has the potential to extend the time a heart can be preserved outside the body (Ex Vivo). The first clinical heart transplant using the new method has now been performed at Sk\u00e5ne University Hospital.<\/strong><\/div>\n<p><span>Approximately 6,500 heart transplants are performed in the world each year and the limiting factor for more heart transplants are the lack of donated hearts and that the generally accepted maximum transport time today is about four hours.\u00a0 The new preservation method includes a machine that supplies the heart with important substances in an oxygenated solution before transplantation. In previous animal experiments using the new method, the preservation time for the donated heart has been extended from today\u2019s approximately four hours to approximately 12 hours.<\/span><\/p>\n<p><span>Sk\u00e5ne University Hospital has obtained ethical approval to initially perform a study including six patents.\u00a0 <\/span><\/p>\n<p><span>If the new method proves to work as well in human beings as in animals, it will be possible to use considerably more hearts for transplantation. In the longer term this will mean that the most suitable recipient can receive the donated organ with distance being less of a limiting factor.<\/span><\/p>\n<p><span>\u201cWe are delighted that the first successful heart transplant using Stig Steen\u2019s new heart solution and machine has now been performed in a human being. Previous results from animal experiments are promising and we look forward to the next stages of the clinical study,\u201d says Magnus Nilsson, XVIVO Perfusion\u2019s CEO.<\/span><\/p>\n<p><span>September 12, 2017<br \/><\/span>Gothenburg<br \/>Magnus Nilsson, CEO<br \/>XVIVO Perfusion AB (publ)<\/p>\n<div class=\"mfn-footer\">\n<p><span>For further information please contact:<\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com<br \/>Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com<\/span><br \/><span>For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/span><\/p>\n<p><span>The information was submitted for publication, through the agency of the contact person set out above, at 2:40 pm CET on September 12, 2017.<\/span><\/p>\n<p><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Through its collaboration agreement with Igel\u00f6sa, XVIVO Perfusion has the commercial rights to Professor Stig Steen\u2019s research on heart transplants&#8230;.<\/p>\n","protected":false},"template":"","class_list":["post-2998","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First clinical heart transplant performed using Stig Steen\u2019s new method - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First clinical heart transplant performed using Stig Steen\u2019s new method - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Through its collaboration agreement with Igel\u00f6sa, XVIVO Perfusion has the commercial rights to Professor Stig Steen\u2019s research on heart transplants....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\\\/\",\"name\":\"First clinical heart transplant performed using Stig Steen\u2019s new method - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2017-09-12T12:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First clinical heart transplant performed using Stig Steen\u2019s new method\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First clinical heart transplant performed using Stig Steen\u2019s new method - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/","og_locale":"en_US","og_type":"article","og_title":"First clinical heart transplant performed using Stig Steen\u2019s new method - XVIVO","og_description":"Through its collaboration agreement with Igel\u00f6sa, XVIVO Perfusion has the commercial rights to Professor Stig Steen\u2019s research on heart transplants....","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/","name":"First clinical heart transplant performed using Stig Steen\u2019s new method - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2017-09-12T12:40:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/first-clinical-heart-transplant-performed-using-stig-steens-new-method\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"First clinical heart transplant performed using Stig Steen\u2019s new method"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}